Osage University Partners

Portfolio Co Investors 2026 for Osage University Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Osage University Partners accounts for 33 tracked companies with verified cap-table data, 33 of which disclose round sizes totalling $5.3B. The median disclosed raise is $100M, and the largest is SiFive at $586M, ahead of ReCode Therapeutics ($570M) and Kymeta ($528M).

The names that recur most often on these co-invested cap tables are Osage University Partners (33 companies), OrbiMed (9 companies), Abingworth (5 companies), 5AM Ventures (5 companies), Sanofi Ventures (4 companies), Atlas Venture (3 companies). By latest disclosed round, the market skews Series B (11), Series A (9), Series C (7), Series E (2).

Best funded Osage University Partners companies

  1. SiFive — $586M (latest: Series G)
  2. ReCode Therapeutics — $570M (latest: Series B)
  3. Kymeta — $528M (latest: Series B)
  4. Delfi Diagnostics — $400M (latest: Series B)
  5. Effector Therapeutics — $325M (latest: Series A)
  6. Escient Pharmaceuticals — $238M (latest: Series C)
  7. ESCAPE Bio — $184M (latest: Series C)
  8. Pairwise Plants — $180M (latest: Series C)
  9. MicroTransponder — $173M (latest: Series E)
  10. AssetWatch — $153M (latest: Series C)
  11. Selecta Biosciences — $151M (latest: Series E)
  12. Neuros Medical — $148M (latest: Series D)
  13. Overland AI — $142M (latest: Series A)
  14. Cyteir Therapeutics — $140M (latest: Series C)
  15. Aptinyx — $135M (latest: Series B)

Osage University Partners — related firms and companies (56)

Osage University Partners alternatives · All research reports